Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
460 - Hi sir. What are the guidelines and regulations for advertising an OTC drug and please can you provide the links?
-
The following guidelines will help you avoid contravening section 9.1 of the Food and Drugs Act. Consumer Advertising http://www.hc-sc.gc.ca/dhp-mps/advert-publicit/pol/guide-ldir_consom_consum-eng.php HCP Advertising PAAB code of Advertising acceptance: http://www.paab.ca/resources/pdfs/PAAB Code Eng Nov 23 2012.pdf See section 2.4.3 for disclosure requirements which are unique to these products. The entire code’s provisions regarding evidence for claims of benefit apply equally to prescription and non-prescription products. The PAAB preclearance system helps ensure compliance with the PAAB code.
